Frequency-reduction strategy of roxadustat in patients undergoing peritoneal dialysis: a multi-center retrospective cohort study
Compared to the dose-reduction group, the frequency-reduction group showed higher hemoglobin target attainment rates, lower hemoglobin variability, and a reduced risk of hemoglobin target non-attainment. The frequency-reduction strategy appears to be a potential tapering approach for peritoneal dialysis (PD) patients.
Authors
- Yanhong Lin (ORCID: https://orcid.org/0009-0006-2935-2896)
- Xin Dou (ORCID: https://orcid.org/0009-0008-8345-9904)
- Jun Ai (ORCID: https://orcid.org/0000-0003-4735-5258)
- Xi Li (ORCID: https://orcid.org/0000-0001-6325-3230)
- Xiaoyan Su
- Guanying Lin
- Xiaohong Zhong
- Yijing Fang
- Xi Mi
- Lu Zhu
Institutions
- Tung Wah Hospital (CN)
- Key Laboratory of Guangdong Province (CN)
- The First People's Hospital of Shunde (CN)
- Nanfang Hospital (CN)
- Shenzhen Chronic Disease Prevention Center (CN)
- National Clinical Research (US)
- Southern Medical University (CN)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2026-01-14
- DOI
- https://doi.org/10.3389/fmed.2025.1708916
- Primary Topic
- Dialysis and Renal Disease Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Southern Medical University
- Nanfang Hospital
- Project 211